Recurrent Breast Cancer Clinical Trials in Barcelona
2 recruitingBarcelona, Spain
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Metastatic Breast CancerHormone Receptor Positive HER-2 Negative Breast CancerRecurrent Breast Cancer
Puma Biotechnology, Inc.150 enrolled53 locationsNCT06369285
Recruiting
Reoperative Sentinel Lymph Node Biopsy in Patients With Recurrent Ipsilateral Breast Cancer
Recurrent Breast Cancer
Hospital Clinic of Barcelona97 enrolled1 locationNCT06329089